U.S. Markets closed


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.000.00 (0.00%)
People also watch
Full screen
Previous Close0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Avg. VolumeN/A
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Accesswire2 years ago

    GenSpera Inc. - "An Evening At The Hudson Union Society"

    NEW YORK, NY / ACCESSWIRE / December 9, 2015 / GenSpera Inc. (OTCQB: GNSZ) today published a new blog post on The Chairman's Blog, written by the Company's chief executive officer, Craig Dionne, Ph.D. ...

  • Zacks Small Cap Research2 years ago

    GNSZ: Mipsagargin Shows Clinical Benefit in Subset of Glioblastoma Patients

    On November 13, 2015, GenSpera, Inc. (GNSZ) filed form 10-Q with financial results for the third quarter of 2015. The company’s previously planned clinical trial in prostate cancer has been postponed until the second quarter of 2016 while the planned clinical trial in renal cell carcinoma (RCC) has been suspended indefinitely.

  • We're sorry this is all we were able to find about this topic.